Lebovits Chaim (CIK 0001406302)

Latest company ownership

Shares held
2,000,847
Last filed at
Jul 31, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 30, 2024 Oct 2, 2024 BRAINSTORM CELL THERAPEUTICS INC. CEO Buy 78.8 +23,836 1.73% ✗ $11.3K
May 28, 2024 Jul 31, 2024 BRAINSTORM CELL THERAPEUTICS INC. CEO Buy 60.0 +15,000 0.48% ✗ $7.8K
May 21, 2024 Jul 31, 2024 BRAINSTORM CELL THERAPEUTICS INC. CEO Buy 78.8 +50,000 1.61% ✗ $30.5K
May 10, 2024 Jul 31, 2024 BRAINSTORM CELL THERAPEUTICS INC. CEO Buy 78.8 +40,000 1.31% ✗ $18.9K
May 7, 2024 Jul 31, 2024 BRAINSTORM CELL THERAPEUTICS INC. CEO Buy 78.8 +66,300 2.21% ✗ $24.8K
May 6, 2024 Jul 31, 2024 BRAINSTORM CELL THERAPEUTICS INC. CEO Buy 87.5 +135,000 4.72% ✗ $50.7K
Apr 19, 2024 Jul 31, 2024 BRAINSTORM CELL THERAPEUTICS INC. CEO Buy 67.5 +15,000 0.53% ✗ $7.8K
Apr 17, 2024 Jul 31, 2024 BRAINSTORM CELL THERAPEUTICS INC. CEO Buy 90.0 +245,072 9.43% ✗ $131.4K